IT1190361B - Composizione farmaceutica in crema per uso dermale ed oftalmico - Google Patents

Composizione farmaceutica in crema per uso dermale ed oftalmico

Info

Publication number
IT1190361B
IT1190361B IT20970/85A IT2097085A IT1190361B IT 1190361 B IT1190361 B IT 1190361B IT 20970/85 A IT20970/85 A IT 20970/85A IT 2097085 A IT2097085 A IT 2097085A IT 1190361 B IT1190361 B IT 1190361B
Authority
IT
Italy
Prior art keywords
cream
dermal
pharmaceutical composition
ophthalmic use
active ingredient
Prior art date
Application number
IT20970/85A
Other languages
English (en)
Other versions
IT8520970A0 (it
Inventor
Annibale Gazzaniga
Federico Stroppolo
Valter Gianesello
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT20970/85A priority Critical patent/IT1190361B/it
Publication of IT8520970A0 publication Critical patent/IT8520970A0/it
Priority to JP61125583A priority patent/JPH0764745B2/ja
Priority to EP86107343A priority patent/EP0205051B1/en
Priority to AT86107343T priority patent/ATE43244T1/de
Priority to DE8686107343T priority patent/DE3663449D1/de
Application granted granted Critical
Publication of IT1190361B publication Critical patent/IT1190361B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT20970/85A 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico IT1190361B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT20970/85A IT1190361B (it) 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico
JP61125583A JPH0764745B2 (ja) 1985-05-30 1986-05-29 皮膚科ならびに眼科用の外傷、潰瘍治療用クリーム剤
EP86107343A EP0205051B1 (en) 1985-05-30 1986-05-30 A pharmaceutical composition in the form of a cream for dermal and ophthalmic use
AT86107343T ATE43244T1 (de) 1985-05-30 1986-05-30 Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
DE8686107343T DE3663449D1 (en) 1985-05-30 1986-05-30 A pharmaceutical composition in the form of a cream for dermal and ophthalmic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20970/85A IT1190361B (it) 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico

Publications (2)

Publication Number Publication Date
IT8520970A0 IT8520970A0 (it) 1985-05-30
IT1190361B true IT1190361B (it) 1988-02-16

Family

ID=11174785

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20970/85A IT1190361B (it) 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico

Country Status (5)

Country Link
EP (1) EP0205051B1 (it)
JP (1) JPH0764745B2 (it)
AT (1) ATE43244T1 (it)
DE (1) DE3663449D1 (it)
IT (1) IT1190361B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
WO1989001489A1 (en) * 1987-08-10 1989-02-23 Commonwealth Scientific And Industrial Research Or Control of angiogenesis and compositions and methods therefor
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US5051443A (en) * 1988-10-12 1991-09-24 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5032575A (en) * 1988-10-12 1991-07-16 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
JPH04305528A (ja) * 1991-02-22 1992-10-28 Dai Ichi Seiyaku Co Ltd ケラチノサイト及び皮膚線維芽細胞の増殖刺激剤
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5290920A (en) * 1992-04-16 1994-03-01 Allelix Biopharmaceuticals Inc. Method of purifying human epidermal growth factor
FR2695557A1 (fr) * 1992-09-15 1994-03-18 Rochas Sa Parfums Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
FR2695556B1 (fr) * 1992-09-15 1995-03-24 Rochas Sa Parfums Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
KR102114993B1 (ko) * 2015-10-15 2020-05-25 주식회사 파이안에스테틱스 폴리펩타이드 및/또는 세포 배양 여액을 함유하는 수용성 스크럽 입자를 포함하는 화장제 조성물
CN110652493A (zh) * 2019-10-31 2020-01-07 福建蓝昊肽生物科技发展有限公司 一种增加生物活性肽乳膏稳定性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380839D1 (en) * 1983-11-02 1989-12-21 J C R Kabushiki Kaisha Also Kn Ophthalmic preparations
JPS615006A (ja) * 1984-06-19 1986-01-10 Sanki Shoji Kk 皮膚用剤

Also Published As

Publication number Publication date
EP0205051A1 (en) 1986-12-17
JPS6227A (ja) 1987-01-06
IT8520970A0 (it) 1985-05-30
EP0205051B1 (en) 1989-05-24
DE3663449D1 (en) 1989-06-29
ATE43244T1 (de) 1989-06-15
JPH0764745B2 (ja) 1995-07-12

Similar Documents

Publication Publication Date Title
IT1190361B (it) Composizione farmaceutica in crema per uso dermale ed oftalmico
EP0336901A3 (en) Anesthetic skin moisturizing composition and method of preparing same
IL103920A (en) Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ZA885192B (en) Pharmaceutical preparations
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2194055T3 (es) Nuevo uso de prostaglandinas.
CA2135346A1 (en) Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also presents antiinflamatory activity
IT1240683B (it) Composizione farmaceutica contenente egf
SE8703210D0 (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
AU624079B2 (en) Novel fluorinated derivatives of amino acids usable more particularly as surfactants or cosurfactants and preparations for biomedical use incorporating these derivatives
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0265042A3 (en) Ophthalmic compositions comprising a tetraalkyl pyrazine
FR2616325B1 (fr) Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone
NO892495L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparat.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
SE8705035D0 (sv) Anvendning av alkylglycerol
FR2392674A1 (fr) Compositions pharmaceutiques a base d'elastine
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
DE3665403D1 (en) Pharmaceutical composition for topical application
AU591748B2 (en) Hair care compositions
IT1233426B (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle
DE3573724D1 (en) Use of 1,8,9-triacetoxy-anthracene as the active ingredient in the preparation of an antitumoral pharmaceutical compound